Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Acute toxicity oral: LD50 for rats is greater than 10000 mg/kg bw.
Acute toxicity: dermal: LD50 is 20000 mg/kg bw.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Referenceopen allclose all

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: A scientific publication peer reviewed.
Principles of method if other than guideline:
LC50 oral (gavage) determined in mouse.
GLP compliance:
not specified
Test type:
acute toxic class method
Species:
mouse
Strain:
not specified
Sex:
not specified
Route of administration:
oral: gavage
Control animals:
not specified
Sex:
not specified
Dose descriptor:
LD50
Effect level:
9 000 mg/kg bw
Interpretation of results:
GHS criteria not met
Conclusions:
LD50 = 9000 mg/kg bw (mice)
Executive summary:

The LD50 of isobornyl acetate in mice (gavage) is 9000 mg/kg bw.

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: A scientific review (peer reviewed). No data on GLP.
Principles of method if other than guideline:
No data on the method.
GLP compliance:
not specified
Test type:
other: no data
Species:
rat
Sex:
not specified
Route of administration:
oral: unspecified
Control animals:
not specified
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 10 000 mg/kg bw
Based on:
test mat.
Interpretation of results:
GHS criteria not met
Conclusions:
Oral LD50 (rats) is greater than 10g/kg/bw.
Executive summary:

The oral LD50 of isobornyl acetate determined in rats is greater than 10g/kg/bw.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
10 000 mg/kg bw
Quality of whole database:
Reliable

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Link to relevant study records
Reference
Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: A scientific review (peer reviewed). No data on GLP.
Principles of method if other than guideline:
No data provided on the method.
GLP compliance:
no
Test type:
other: no data
Species:
rabbit
Strain:
not specified
Sex:
not specified
Sex:
not specified
Dose descriptor:
LD50
Effect level:
20 000 mg/kg bw
Based on:
test mat.
Interpretation of results:
GHS criteria not met
Conclusions:
The dermal LD50 in rabbit is greater than 20000 mg/kg bw
Executive summary:

The dermal LD50 of Isobornyl acetate for rabbits is greater than 20000 mg/kg bw.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
20 000 mg/kg bw

Additional information

Acute toxicity, oral:

Weight of evidence: The oral LD50 determined in rats is greater than 10000 mg/kg/bw.

Weight of evidence: The LD50 in mice (gavage) is 9000 mg/kg bw.

Acute toxicity, dermal:

Key Study: The dermal LD50 of Isobornyl acetate for rabbits is greater than 20000 mg/kg bw.

Justification for classification or non-classification

Acute toxicity:

Oral: LD50>2000mg/kg bw: non classified

Dermal: LD50>2000mg/kg bw: non classified